<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=2-20_PAIN_MANAGEMENT</id>
	<title>2-20 PAIN MANAGEMENT - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=2-20_PAIN_MANAGEMENT"/>
	<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=2-20_PAIN_MANAGEMENT&amp;action=history"/>
	<updated>2026-04-20T15:31:16Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.37.2</generator>
	<entry>
		<id>https://www.crsguidelines.org/index.php?title=2-20_PAIN_MANAGEMENT&amp;diff=178&amp;oldid=prev</id>
		<title>Cgabryszek at 20:06, 6 November 2025</title>
		<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=2-20_PAIN_MANAGEMENT&amp;diff=178&amp;oldid=prev"/>
		<updated>2025-11-06T20:06:29Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 15:06, 6 November 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l27&quot;&gt;Line 27:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 27:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Protocol:&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Protocol:&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|&lt;/del&gt;&amp;#039;&amp;#039;&amp;#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Intermediate &lt;/del&gt;-&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Perform&lt;/del&gt;/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Confirm All Above Interventions&lt;/del&gt;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;#039;&amp;#039;EMT - Emergency Medical Technician&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|} &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;# Obtain vital signs and allergies&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;# Ask patient to rate pain&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;# If the patient indicates mild to moderate extremity pain and has no evidence of open fracture, obvious dislocation, or obvious deformity administer acetaminophen 500 mg orally.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;#039;&amp;#039;&amp;#039;INTERMEDIATE &lt;/ins&gt;-&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PERFORM&lt;/ins&gt;/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;CONFIRM ALL ABOVE INTERVENTIONS&lt;/ins&gt;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Obtain vital signs and allergies&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Obtain vital signs and allergies&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l35&quot;&gt;Line 35:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 40:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Establish an IV of NS TKO&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Establish an IV of NS TKO&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# If patient indicates a pain scale of greater than 5 and has no signs of poor perfusion or respiratory depression:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# If patient indicates a pain scale of greater than 5 and has no signs of poor perfusion or respiratory depression:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;## For patients 6-75 years old: Administer &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5-1 mcg/kg INTRANASAL/INTRAMUSCULAR or mixed in 5 mL normal saline and given IV/IO push over 2-4 minutes to a maximum single dose of 100 mcg IV&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;/IO&lt;/del&gt;. Reassess patient vital signs and pain scale after 5 minutes.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;## For patients 6-75 years old: Administer &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5-1 mcg/kg INTRANASAL/INTRAMUSCULAR or mixed in 5 mL normal saline and given IV/IO push over 2-4 minutes to a maximum single dose of 100 mcg IV. Reassess patient vital signs and pain scale after 5 minutes.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;## For patients &amp;gt; 75 years old: Administer &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5 mcg/kg INTRANASAL/INTRAMUSCULAR or mixed in 5 mL normal saline and given IV/IO push over 2-4 minutes to a maximum single dose of 100 mcg IV/IO. Reassess patient vital signs and pain scale after 5 minutes.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;## For patients &amp;gt; 75 years old: Administer &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5 mcg/kg INTRANASAL/INTRAMUSCULAR or mixed in 5 mL normal saline and given IV/IO push over 2-4 minutes to a maximum single dose of 100 mcg IV/IO. Reassess patient vital signs and pain scale after 5 minutes.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Reassess pain scale and vital signs including pulse oximetry every 5 minutes&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Reassess pain scale and vital signs including pulse oximetry every 5 minutes&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# If sufficient pain relief is not obtained with the initial dose, then an additional dose of &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5 mcg/kg may be administered IV, IN, IM, or IO provided systolic BP remains above 100 mm Hg for a total max dose of 150 mcg&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# If sufficient pain relief is not obtained with the initial dose, then an additional dose of &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5 mcg/kg may be administered IV, IN, IM, or IO provided systolic BP remains above 100 mm Hg for a total max dose of 150 mcg&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# &amp;#039;&amp;#039;&amp;#039;Ondansetron (Zofran&amp;#039;&amp;#039;&amp;#039;) 4 mg IV or IN may be administered for control of patient nausea as needed with or without pain medication. &amp;#039;&amp;#039;&amp;#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Consult&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;&amp;#039;Medical Control&lt;/del&gt;&amp;#039;&amp;#039;&amp;#039; for further doses of Zofran if sufficient relief is not obtained.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# &amp;#039;&amp;#039;&amp;#039;Ondansetron (Zofran&amp;#039;&amp;#039;&amp;#039;) 4 mg IV&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;/IO &lt;/ins&gt;or IN may be administered for control of patient nausea as needed with or without pain medication. &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;c&lt;/ins&gt;&amp;#039;&amp;#039;&amp;#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ontact ☎ MEDICAL CONTROL ☎&lt;/ins&gt;&amp;#039;&amp;#039;&amp;#039; for further doses of Zofran if sufficient relief is not obtained.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PARAMEDIC - PERFORM/CONFIRM ALL ABOVE INTERVENTIONS&lt;/ins&gt;&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|&lt;/del&gt;&amp;#039;&amp;#039;&amp;#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Paramedic -&lt;/del&gt;&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Perform/Confirm All Above Interventions&lt;/del&gt;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;If FENTANYL has been administered and 5 minutes have passed without desired effect, or if there is &lt;/del&gt;a &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;contraindication &lt;/del&gt;for &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;administration of FENTANYL (signs of poor perfusion or respiratory depression), Contact MEDICAL CONTROL&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039; for consideration of administration of KETAMINE&lt;/del&gt;.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;For severe pain consider ketamine as &lt;/ins&gt;a &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;first line drug &lt;/ins&gt;for &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;pain&lt;/ins&gt;.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;## &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;If KETAMINE is administered after FENTANYL, the &lt;/del&gt;initial recommended dose of KETAMINE is 0.5mg/kg IV&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;/IN&lt;/del&gt;/IO &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or 2mg&lt;/del&gt;/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kg IM&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;## &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The &lt;/ins&gt;initial recommended dose of KETAMINE is 0.5mg/kg IV/IO/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;IN&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;## If KETAMINE is administered and there are any signs of emergence phenomena, such as hallucinations, delirium, or increasing agitation, &amp;#039;&amp;#039;&amp;#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;contact&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;&amp;#039;medical control&lt;/del&gt;&amp;#039;&amp;#039;&amp;#039; for discussion of supplemental Versed.  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;## If KETAMINE is administered and there are any signs of emergence phenomena, such as hallucinations, delirium, or increasing agitation, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;c&lt;/ins&gt;&amp;#039;&amp;#039;&amp;#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ontact ☎ MEDICAL CONTROL ☎&lt;/ins&gt;&amp;#039;&amp;#039;&amp;#039; for discussion of supplemental Versed.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Initiate transport and &amp;#039;&amp;#039;&amp;#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Contact &lt;/del&gt;MEDICAL CONTROL&amp;#039;&amp;#039;&amp;#039; for further orders.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Initiate transport and &amp;#039;&amp;#039;&amp;#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;contact ☎ &lt;/ins&gt;MEDICAL CONTROL &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;☎&lt;/ins&gt;&amp;#039;&amp;#039;&amp;#039; for further orders.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Reassess vital signs, mental status, pain level and respiratory effort and if continued pain over 5, &amp;#039;&amp;#039;&amp;#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Contact &lt;/del&gt;MEDICAL CONTROL&amp;#039;&amp;#039;&amp;#039; for any further dosages.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Reassess vital signs, mental status, pain level and respiratory effort and if continued pain over 5, &amp;#039;&amp;#039;&amp;#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;contact ☎ &lt;/ins&gt;MEDICAL CONTROL &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;☎&lt;/ins&gt;&amp;#039;&amp;#039;&amp;#039; for any further dosages.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Cgabryszek</name></author>
	</entry>
	<entry>
		<id>https://www.crsguidelines.org/index.php?title=2-20_PAIN_MANAGEMENT&amp;diff=58&amp;oldid=prev</id>
		<title>Cgabryszek: Created page with &quot;&#039;&#039;&#039;Purpose:&#039;&#039;&#039; To ensure that pain and nausea are appropriately addressed in the field to promote safe and comfortable management and transport of the patient.  &#039;&#039;&#039;Inclusion Criteria&#039;&#039;&#039; without prior Medical Control Authorization:  # Musculoskeletal injury # Burns # Chest Pain # Abdominal or flank pain # Age greater than 6 # Systolic BP &gt; 100 mm Hg in an adult # Now known allergies to medications being administered # No known exclusion criteria present  &#039;&#039;&#039;Inclusion Crit...&quot;</title>
		<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=2-20_PAIN_MANAGEMENT&amp;diff=58&amp;oldid=prev"/>
		<updated>2022-04-03T22:42:03Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;#039;&amp;#039;&amp;#039;Purpose:&amp;#039;&amp;#039;&amp;#039; To ensure that pain and nausea are appropriately addressed in the field to promote safe and comfortable management and transport of the patient.  &amp;#039;&amp;#039;&amp;#039;Inclusion Criteria&amp;#039;&amp;#039;&amp;#039; without prior Medical Control Authorization:  # Musculoskeletal injury # Burns # Chest Pain # Abdominal or flank pain # Age greater than 6 # Systolic BP &amp;gt; 100 mm Hg in an adult # Now known allergies to medications being administered # No known exclusion criteria present  &amp;#039;&amp;#039;&amp;#039;Inclusion Crit...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Purpose:&amp;#039;&amp;#039;&amp;#039; To ensure that pain and nausea are appropriately addressed in the field to promote safe and comfortable management and transport of the patient.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Inclusion Criteria&amp;#039;&amp;#039;&amp;#039; without prior Medical Control Authorization:&lt;br /&gt;
&lt;br /&gt;
# Musculoskeletal injury&lt;br /&gt;
# Burns&lt;br /&gt;
# Chest Pain&lt;br /&gt;
# Abdominal or flank pain&lt;br /&gt;
# Age greater than 6&lt;br /&gt;
# Systolic BP &amp;gt; 100 mm Hg in an adult&lt;br /&gt;
# Now known allergies to medications being administered&lt;br /&gt;
# No known exclusion criteria present&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Inclusion Criteria&amp;#039;&amp;#039;&amp;#039; that require &amp;#039;&amp;#039;&amp;#039;Medical Control&amp;#039;&amp;#039;&amp;#039; contact prior to medication administration:&lt;br /&gt;
&lt;br /&gt;
# Pregnancy&lt;br /&gt;
# Age &amp;lt;6 (may require dosage adjustment)&lt;br /&gt;
# Weight &amp;lt;20 kg (may require dosage adjustment)&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Exclusion Criteria:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Known allergy to medication&lt;br /&gt;
# Respiratory distress with potential for patient fatigue&lt;br /&gt;
# Systolic BP &amp;lt; 100 mm Hg&lt;br /&gt;
# Altered Mental Status&lt;br /&gt;
# Multi System Trauma&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Protocol:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;Intermediate -&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;Perform/Confirm All Above Interventions&amp;#039;&amp;#039;&lt;br /&gt;
|} &lt;br /&gt;
&lt;br /&gt;
# Obtain vital signs and allergies&lt;br /&gt;
# Ask patient to rate pain on scale of 1 to 10&lt;br /&gt;
# Establish an IV of NS TKO&lt;br /&gt;
# If patient indicates a pain scale of greater than 5 and has no signs of poor perfusion or respiratory depression:&lt;br /&gt;
## For patients 6-75 years old: Administer &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5-1 mcg/kg INTRANASAL/INTRAMUSCULAR or mixed in 5 mL normal saline and given IV/IO push over 2-4 minutes to a maximum single dose of 100 mcg IV/IO. Reassess patient vital signs and pain scale after 5 minutes.&lt;br /&gt;
## For patients &amp;gt; 75 years old: Administer &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5 mcg/kg INTRANASAL/INTRAMUSCULAR or mixed in 5 mL normal saline and given IV/IO push over 2-4 minutes to a maximum single dose of 100 mcg IV/IO. Reassess patient vital signs and pain scale after 5 minutes.&lt;br /&gt;
# Reassess pain scale and vital signs including pulse oximetry every 5 minutes&lt;br /&gt;
# If sufficient pain relief is not obtained with the initial dose, then an additional dose of &amp;#039;&amp;#039;&amp;#039;fentanyl (Sublimaze)&amp;#039;&amp;#039;&amp;#039; 0.5 mcg/kg may be administered IV, IN, IM, or IO provided systolic BP remains above 100 mm Hg for a total max dose of 150 mcg&lt;br /&gt;
# &amp;#039;&amp;#039;&amp;#039;Ondansetron (Zofran&amp;#039;&amp;#039;&amp;#039;) 4 mg IV or IN may be administered for control of patient nausea as needed with or without pain medication. &amp;#039;&amp;#039;&amp;#039;Consult&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;&amp;#039;Medical Control&amp;#039;&amp;#039;&amp;#039; for further doses of Zofran if sufficient relief is not obtained.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;Paramedic -&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;Perform/Confirm All Above Interventions&amp;#039;&amp;#039;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
# If FENTANYL has been administered and 5 minutes have passed without desired effect, or if there is a contraindication for administration of FENTANYL (signs of poor perfusion or respiratory depression), Contact MEDICAL CONTROL&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039; for consideration of administration of KETAMINE.&lt;br /&gt;
## If KETAMINE is administered after FENTANYL, the initial recommended dose of KETAMINE is 0.5mg/kg IV/IN/IO or 2mg/kg IM&lt;br /&gt;
## If KETAMINE is administered and there are any signs of emergence phenomena, such as hallucinations, delirium, or increasing agitation, &amp;#039;&amp;#039;&amp;#039;contact&amp;#039;&amp;#039;&amp;#039; &amp;#039;&amp;#039;&amp;#039;medical control&amp;#039;&amp;#039;&amp;#039; for discussion of supplemental Versed. &lt;br /&gt;
# Initiate transport and &amp;#039;&amp;#039;&amp;#039;Contact MEDICAL CONTROL&amp;#039;&amp;#039;&amp;#039; for further orders.&lt;br /&gt;
# Reassess vital signs, mental status, pain level and respiratory effort and if continued pain over 5, &amp;#039;&amp;#039;&amp;#039;Contact MEDICAL CONTROL&amp;#039;&amp;#039;&amp;#039; for any further dosages.&lt;/div&gt;</summary>
		<author><name>Cgabryszek</name></author>
	</entry>
</feed>